Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCF

被引:87
作者
Klenova, EM
Chernukhin, IV
El-Kady, A
Lee, RE
Pugacheva, EM
Loukinov, DI
Goodwin, GH
Delgado, D
Filippova, GN
León, J
Morse, HC
Neiman, PE
Lobanenkov, VV
机构
[1] NIAID, Immunopathol Lab, Sect Mol Pathol, NIH, Bethesda, MD 20892 USA
[2] NIAID, Immunopathol Lab, Virol & Cellular Immunol Sect, NIH, Bethesda, MD 20892 USA
[3] Univ Oxford, Dept Biochem, Genet Lab, Oxford OX1 3QU, England
[4] Inst Canc Res, Haddow Labs, Sutton, Surrey, England
[5] Univ Cantabria, Fac Med, Santander 39011, Spain
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
关键词
D O I
10.1128/MCB.21.6.2221-2234.2001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CTCF is a widely expressed and highly conserved multi-Zn-finger (ZF) nuclear factor. Binding to various CTCF target sites (CTSs) is mediated by combinatorial contributions of different ZFs. Different CTSs mediate distinct CTCF functions in transcriptional regulation, including promoter repression or activation and hormone-responsive gene silencing. In addition, the necessary and sufficient core sequences of diverse enhancer-blocking (insulator) elements, including CpG methylation-sensitive ones, have recently been pinpointed to CTSs. To determine whether a posttranslational modification may modulate CTCF functions, we studied CTCF phosphorylation. We demonstrated that most of the modifications that occur at the carboxy terminus in vivo can be reproduced in vitro with casein kinase II (CKII). Major modification sites map to four serines within the (SKKEDSSDSE)-K-604-S-609-D-610-E-612 motif that is highly conserved in vertebrates. Specific mutations of these serines abrogate phosphorylation of CTCF in vivo and CKII-induced phosphorylation in vitro. In addition, we showed that completely preventing phosphorylation by substituting all serines within this site resulted in markedly enhanced repression of the CTS-bearing vertebrate c-myc promoters, but did not alter CTCF nuclear localization or in vitro DNA-binding characteristics assayed with c-myc CTSs. Moreover, these substitutions manifested a profound effect on negative cell growth regulation by wild-type CTCF. CKII may thus be responsible for attenuation of CTCF activity, either acting on its own or by providing the signal for phosphorylation by other kinases and for CTCF-interacting protein partners.
引用
收藏
页码:2221 / 2234
页数:14
相关论文
共 66 条
[1]   PROTEIN KINASES .4. PROTEIN-KINASE CK2 - AN ENZYME WITH MULTIPLE SUBSTRATES AND A PUZZLING REGULATION [J].
ALLENDE, JE ;
ALLENDE, CC .
FASEB JOURNAL, 1995, 9 (05) :313-323
[2]   Pausing for thought on the boundaries of imprinting [J].
Allshire, R ;
Bickmore, W .
CELL, 2000, 102 (06) :705-708
[3]   AT-hook motifs identified in a wide variety of DNA binding proteins [J].
Aravind, L ;
Landsman, D .
NUCLEIC ACIDS RESEARCH, 1998, 26 (19) :4413-4421
[4]   Casein kinase II-mediated phosphorylation of the C terminus of spl decreases its DNA binding activity [J].
Armstrong, SA ;
Barry, DA ;
Leggett, RW ;
Mueller, CR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (21) :13489-13495
[5]   Negative transcriptional regulation mediated by thyroid hormone response element 144 requires binding of the multivalent factor CTCF to a novel target DNA sequence [J].
Awad, TA ;
Bigler, J ;
Ulmer, JE ;
Hu, YJ ;
Moore, JM ;
Lutz, M ;
Neiman, PE ;
Collins, SJ ;
Renkawitz, R ;
Lobanenkov, VV ;
Filippova, GN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (38) :27092-27098
[6]   Stopped at the border: boundaries and insulators [J].
Bell, AC ;
Felsenfeld, G .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (02) :191-198
[7]   The protein CTCF is required for the enhancer blocking activity of vertebrate insulators [J].
Bell, AC ;
West, AG ;
Felsenfeld, G .
CELL, 1999, 98 (03) :387-396
[8]   Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene [J].
Bell, AC ;
Felsenfeld, G .
NATURE, 2000, 405 (6785) :482-485
[9]   DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site [J].
Blaydes, JP ;
Hupp, TR .
ONCOGENE, 1998, 17 (08) :1045-1052
[10]  
BOUSSET K, 1994, CELL MOL BIOL RES, V40, P501